From Proteome to Prediction: Multi-Omic Strategies Driving Clinical Trial Breakthroughs

Register below for our speaker session

Tuesday, June 3 | 12:15–1:15 pm
Mile High 4D, Level 4

Join Helen McGuire, PhD, for a compelling look into how integrated multi-omic platforms – including mass cytometry and spatial proteomics – are delivering deeper insights and advancing checkpoint inhibitor response prediction in clinical trials.

What you'll gain:

• Explore how integrated single-cell and spatial proteomics are enhancing predictive power in clinical trial design and response monitoring
• Gain insights into high-dimensional immune profiling strategies that uncover functional cellular states relevant to immunotherapy outcomes
• Learn from case studies demonstrating the translational application of mass cytometry and multi-omic approaches in oncology research

Helen McGuire, PhD

Translational Immunology Group
School of Medical Science
University of Sydney